A tool to help cancer patients overcome travel challenges for radiation therapy
Testing the Feasibility of a Transportation for Cancer Care Navigation Tool (TRACT) in Solid Tumors Patients Receiving Radiotherapy
NA · Emory University · NCT06541158
This study is testing a new tool to help cancer patients with solid tumors get to their radiation therapy appointments more easily and see if it helps them stick to their treatment better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 76 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Emory University (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 4 sites (Atlanta, Georgia and 3 other locations) |
| Trial ID | NCT06541158 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the Transportation for Cancer Care Navigation Tool (TRACT) aimed at reducing travel barriers for patients with solid tumors undergoing radiation therapy. The study involves collaboration with a Community Advisory Board to refine the TRACT program, which includes screening for travel barriers, providing resources, and personalized transportation support. Patients will be randomized into two groups: one receiving the TRACT program and the other receiving standard care with additional informational resources. The trial will assess the feasibility and efficacy of the TRACT program on treatment adherence and patient-reported outcomes over a follow-up period of three months.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with solid tumors who are undergoing radiation therapy and experience travel barriers.
Not a fit: Patients receiving palliative care or those with major depression/anxiety disorders that interfere with participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve treatment adherence and quality of life for cancer patients facing transportation challenges.
How similar studies have performed: While similar approaches to addressing travel barriers in cancer care have been explored, the TRACT program represents a novel intervention specifically tailored for patients undergoing radiation therapy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosed with solid tumors
* Undergoing RT (not excluded with chemotherapy)
* Competent to give consent
* English-speaking
* With travel barriers as screened by the reliable and validated 10-item Transportation Barriers Measure. In this study, item 2 ("how much trouble is it for you to get transportation to your doctor or treatment?") from the general barriers domain will be used to screen patients for travel barriers
Exclusion Criteria:
* Receive palliative care
* Are non-English-speaking (excluded due to pilot data without fund to support translation services)
* Are enrolled in lodging programs (e.g., the American Cancer Society \[ACS\] Hope Lodge®)
* Have major depression/anxiety disorders that interfere with their ability to participate (based on the electronic medical records report)
Where this trial is running
Atlanta, Georgia and 3 other locations
- Emory Proton Therapy Center — Atlanta, Georgia, United States (NOT_YET_RECRUITING)
- Emory University Hospital Midtown — Atlanta, Georgia, United States (RECRUITING)
- Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States (RECRUITING)
- Emory Saint Joseph's Hospital — Atlanta, Georgia, United States (RECRUITING)
Study contacts
- Principal investigator: Jinbing Bai — Emory University Hospital/Winship Cancer Institute
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Malignant Solid Neoplasm